Developing Viability Index for Machine Perfused Livers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMassachusetts General Hospital

About this trial

Machine perfusion technology is nearing the point of rescuing discarded liver grafts in the hope of proving them to be or improving them to the point of being transplantable. However, there are no validated metrics to determine transplantability after machine perfusion. This study involves collecting biopsies from transplanted livers before and after implantation to correlate metabolite and gene expression with post-transplant function. This data will help develop a viability index for machine perfused livers.

Eligibility criteria

Qualifiers

Male or female 18-75 years of age.

Candidate for a deceased-donor liver allograft.

Disqualifiers

Seropositivity for HIV-1.

Trial design

Treatments tested in this trial

  • Liver Biopsy

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

Massachusetts General Hospital

Lead sponsor

Brigham and Women's Hospital

Collaborator

Shriners Hospitals for Children

Collaborator